Navigation Links
Diabetes Alliance to Feature 17 Presentations for Linagliptin and Investigational Compound Empagliflozin^ During the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Date:9/17/2013

Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Early Type 2 Diabetes (CAROLINA) (Presenting Author: J. Rosenstock) [Oral Presentation No. 73]

Wednesday, September 25, 12:30 – 1:30 CET, General Poster Sessions

  • Efficacy and Safety of Linagliptin as Add-On Therapy to Basal Insulin and Metformin in Patients with Type 2 Diabetes (Presenting Author: S. Duran-Garcia) [Poster No. 892]

Wednesday, September 25, 3:00 – 4:30 CET, Oral Presentation

  • Cardiovascular (CV) Safety of Linagliptin in Patients with Type 2 Diabetes (T2D): A Pooled Comprehensive Analysis of Prospectively Adjudicated CV Events in Phase 3 Studies (Presenting Author: O. E. Johansen) [Oral Presentation No. 112]
  • Linagliptin and The Angiotensin II Receptor Blocker Telmisartan Show Comparable Efficacy but Different Renoprotective Pathways in Rats with 5/6 Nephrectomy (Presenting Author: B. Hocher) [Oral Presentation No. 143]

Thursday, September 26, 10:45 – 12:15 CET, Oral Presentation

  • Insights into the Mechanism of Action of Linagliptin in Reducing Ischaemic Brain Damage Following Stroke in Diabetic and Non-Diabetic Mice (Presenting Author: V. Darsalia) [Oral Presentation No. 152]

Thursday, September 26, 12:30 – 1:30 CET, General Poster Session

  • Renal Safety and Outcomes with Linagliptin: Meta-Analysis of Individual Data for 5466 Patients with Type 2 Diabetes (Presenting Author: M. von Eynatten) [Poster No. 913]
  • Linagliptin Versus Placebo Followed by Glimepiride in Type 2 Diabetes Patients with Moderate to Severe Renal Impairment (Presenting Author: P-H. Groop) [Poster No. 914]'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Inc. (OTCQB:ECIA), a medical device company owning patented surgical ... invasive surgery, today announced financial results for its fiscal ... 2015. The Company posted quarterly net revenue ... $349 thousand, or $(0.03) per share. These results compare ... loss of $1.453 million, or $(0.14) per share, in ...
(Date:5/27/2015)... , May 27, 2015 Biosensors International Group, ... Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer ... its fourth fiscal quarter ("Q4 FY15") and fiscal full ... Highlights and Recent Developments: , Q4 FY15: ... from the fourth quarter of Fiscal Year 2014 ("Q4 ...
(Date:5/27/2015)... , May 27, 2015 AtCor Medical ... SphygmoCor ® system which measures central aortic blood ... a panel US medical experts for physicians on the ... patient care. The article, "Clinical Use of Pulse ... American Artery " was published in the Journal of ...
Breaking Medicine Technology:Encision Reports Fourth Quarter And Fiscal Year 2015 Results 2Encision Reports Fourth Quarter And Fiscal Year 2015 Results 3Encision Reports Fourth Quarter And Fiscal Year 2015 Results 4Encision Reports Fourth Quarter And Fiscal Year 2015 Results 5Encision Reports Fourth Quarter And Fiscal Year 2015 Results 6Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7Expert panel publishes guidance for central aortic pressure waveform analysis in patient care 2Expert panel publishes guidance for central aortic pressure waveform analysis in patient care 3
(Date:5/27/2015)... May 27, 2015 According to research ... Southwestern Medical Center at Dallas some migraine patients have ... CTS and migraine headache apparently also have some shared ... of obesity, people with a history of diabetes and/or ... in Asians, and CTS in particular was less common ...
(Date:5/27/2015)... The Advanced Fertility Center of Chicago announces that their ... better serve the needs of couples in Chicagoland. The ... Northwest side of the city at 4920 North Central Ave., ... the Chicago office at (773) 794–1818. This is the ... The other 2 offices are in Gurnee and Crystal ...
(Date:5/26/2015)... Carey Danis & Lowe ... lawsuit . The suit pertains to AndroGel, a testosterone ... in late April 2015, and a court document relating ... court in mid-May.¹ , Testosterone gel lawsuits are being ... District of Illinois. The multidistrict litigation (MDL) is In ...
(Date:5/26/2015)... 2015 Securityhunter has been ... the United States Department of Health and Human Services ... The MATOC was awarded through the General Services Administration ... the PSC, which is a fee-for-service agency. The award ... options, and is an enterprise–wide physical security and security ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Forex Income ... interested in improving their results trading in the foreign ... trader Russ Horn, utilizes 10 customer indicators to help ... consistency. , "As usual, Russ Horn's latest trading system ... Forex trading community," reports Tiffany Hendricks, senior product reviewer ...
Breaking Medicine News(10 mins):Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 2Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 4Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Carey Danis & Lowe Comments on Recently Filed Testosterone Gel Lawsuit 2Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2Health News:Forex Income Boss - Review Of Russ Horn's New FX Trading System Released 2
... Universities of Warwick, Edinburgh, Dundee and the Czech Republics ... compound that is up to 80 times more powerful ... light activation to kill cancer cells in much ... compound known as trans, trans, trans- [Pt(N3)2(OH)2(NH3)(py)], or ...
... Inc.,(Amex: PLC ) announced today that it has ... the way for the Company to begin,its initial launch ... to initiate a limited launch of RenalGuard(TM) in the ... recognize the benefits of,utilizing the unique fluid balancing capabilities ...
... HealthSouth,Corporation (NYSE: HLS ) announced today that its ... $16.25 per share on its 6.5%,Series A Convertible Perpetual ... record on January 2, 2008., About HealthSouth, ... Operating in 27 states across the country and in,Puerto ...
... The Greater Detroit Area Health,Council,s (GDAHC) ... partnership,with the American Diabetes Association, sanofi-aventis, and ... program to help people with,diabetes better manage ... connect,employers, community organizations and labor groups with ...
... linked, research suggests , FRIDAY, Dec. 21 (HealthDay News) -- ... diabetes, concludes a University of Pennsylvania School of Medicine study ... . , It found that providing depression care management to ... death over five years by about 50 percent. , "Depression ...
... Makes Results from Burdick(R) and, Quinton(R) branded products from Cardiac Science ... ... 5.0, BOTHELL, Wash. and MELVILLE, N.Y., ... provider of cardiac,monitoring, defibrillation and rehabilitative products, and Henry Schein,Medical Systems, ...
Cached Medicine News:Health News:Light powered platinum more targeted and 80 times more powerful than similar cancer treatments 2Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 2Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 3Health News:PLC Systems Receives CE Mark Approval for RenalGuard(TM) 4Health News:HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock 2Health News:GDAHC Save Lives Save Dollars Initiative Launches Pilot Program for Diabetes Care Management 2Health News:GDAHC Save Lives Save Dollars Initiative Launches Pilot Program for Diabetes Care Management 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 2Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 3Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 4Health News:Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems' MicroMD(R) EMR 5.0 5
The WADiana Compact is a fully automated immuno-haematology analyser, easy to use with maximum security including clot detection and ensuring no contamination....
... PK7200 works on patented microplate agglutination ... testing system for donor ABO/Rh testing. PK7200 ... syphilis and cytomegalovirus antibody detection. The Automated ... along with the proven reliability that for ...
... Tecan Haemotyper is an automated ... The Tecan Haemotyper combines a ... platform with the DiaMed agglutination ... process DiaMed-ID cards and microplates ...
... the "Reversed" shoulder prosthesis has been used ... More recently, an ever-growing number of surgeons ... champion this prosthesis and the associated surgical ... technology is the result of nearly fifteen ...
Medicine Products: